The drug is called ipilimumab. Before it came along there were no successful treatments for advanced melanoma and less than 3% of patients survived for five years. Now, with immunotherapy regimens ...

Melanoma Among Adult Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study Adults with stage IB-IIIA (American Joint Committee on Cancer seventh edition) resectable NSCLC ...

Pembrolizumab, nivolumab and ipilimumab can affect the immune system ... You should tell them that you are on or have been on an immunotherapy. Your doctor will talk to you about the possible side ...

Immunotherapy nevertheless breaks down these ... The BBC reports that an international trial on 945 patients found treatment with ipilimumab and nivolumab stopped the cancer advancing for nearly ...

Cancer immunotherapy is a therapy used to treat ... the authors investigate triplet combination of sitravatinib with nivolumab and ipilimumab (anti-CTLA4) in patients with metastatic ccRCC and ...

Lung cancer immunotherapy has not been successful ... In patients with advanced NSCLC, ipilimumab, an anti-CTLA-4 mAb, improved progression-free survival in a randomized Phase II study when ...

Immunotherapy is Nobel Prize-winning science ... unlike its healthy neighbours Ipilimumab and nivolumab both stop some cancers from hiding and allow the immune system to attack.

Our study examines how different imaging criteria can be used to assess brain tumor responses in patients with melanoma treated with immunotherapy drugs. We identified one imaging method that was ...